SCHEMBL1907904

SCHEMBL1907904

CC(C)(C)O[N]C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8022220 0.65
SCHEMBL1562430 0.62
SCHEMBL27393 0.62
SCHEMBL28733048 0.60 ALDH1A1 (0.36)
SCHEMBL23244605 0.60
Hydrochloric Acid SCHEMBL7545996 0.60
Potassium SCHEMBL31609876 0.60
Bromide SCHEMBL17824162 0.60
SCHEMBL31636743 0.60
SCHEMBL3635526 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524657-B2 Peptidic compounds UNIVERSITY OF WOLLONGONG (AU) 2013-09-03 US disclosed
EP-1836159-B1 Antibiotic binaphthyl derivatives UNIV WOLLONGONG (AU) 2013-04-10 EP disclosed
US-8080526-B2 Methods and compositions for the treatment of gastrointestinal disorders IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-20 US disclosed
US-20110124583-A1 Methods and Compositions for the Treatment of Gastrointestinal Disorders IRONWOOD PHARMACEUTICALS, INC. (US) 2011-05-26 US disclosed
EP-2199300-A2 Peptidic compounds The University Of Wollongong (AU) 2010-06-23 EP disclosed
US-20080300287-A1 Peptidic Compounds UNIVERSITY OF WOLLONGONG (AU) 2008-12-04 US disclosed
CN-1889836-A Insecticidal n-(heteroarylalkyl)alkanediamine derivatives FMC CORP (US) 2007-01-03 CN disclosed
EP-1311292-A2 VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS Bristol-Myers Squibb Pharma Company (US) 2003-05-21 EP disclosed
WO-2001097861-A2 VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-12-27 WO disclosed
EP-1140864-A2 VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS Du Pont Pharmaceuticals Company (US) 2001-10-10 EP disclosed
WO-2000035887-A2 VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS DU PONT PHARM CO (US) 2000-06-22 WO disclosed